These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4129483)

  • 1. Activation of the complement system.
    Cooper NR
    Contemp Top Mol Immunol; 1973; 2():155-83. PubMed ID: 4129483
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunobiology of complement.
    Burkholder PM; Littleton CE
    Pathobiol Annu; 1971; 1():215-39. PubMed ID: 4129958
    [No Abstract]   [Full Text] [Related]  

  • 3. [Genetically controlled disorders of the human complement system].
    Brackertz D
    Schweiz Med Wochenschr; 1974 Jun; 104(22):777-84. PubMed ID: 4135190
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of guinea-pig complement by derivatives of benzamidine. I. Effect of p-nitrophenylureido derivative of m-(m-phenoxypropoxy)benzamidine on guinea-pig complement component haemolytic activity.
    Glovsky MM; Cory M; Alenty A
    Immunology; 1974 Apr; 26(4):819-29. PubMed ID: 4136824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic aspects of diseases of complement: an explosion.
    Polley MJ; Bearn AG
    Am J Med; 1975 Jan; 58(1):105-11. PubMed ID: 46701
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzyme activation and the mechanism of neutrophil chemotaxis.
    Becker EL
    Antibiot Chemother (1971); 1974; 19():409-20. PubMed ID: 4142851
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical importance of the complement system].
    Spath P; Huber H
    Wien Klin Wochenschr; 1973 Jun; 85(25):445-50. PubMed ID: 4123223
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemistry and reaction mechanisms of complement.
    Müller-Eberhard HJ
    Adv Immunol; 1968; 8():1-80. PubMed ID: 4174135
    [No Abstract]   [Full Text] [Related]  

  • 9. C1-bypass complement-activation pathway in patients with chronic urticaria and angio-oedema.
    Ballow M; Ward GW; Gershwin ME; Day NK
    Lancet; 1975 Aug; 2(7928):248-50. PubMed ID: 49798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical applications of complement assays.
    Alper CA; Rosen FS
    Adv Intern Med; 1975; 20():61-88. PubMed ID: 46689
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of late complement components and the alternate complement pathway in experimental cryptococcosis.
    Diamond RD; May JE; Kane M; Frank MM; Bennett JE
    Proc Soc Exp Biol Med; 1973 Oct; 144(1):312-5. PubMed ID: 4129497
    [No Abstract]   [Full Text] [Related]  

  • 12. Complement in membranoproliferative (hypocomplementaemic) glomerulonephritis.
    Peters DK
    Ciba Found Symp; 1972; 9():273-82. PubMed ID: 4633536
    [No Abstract]   [Full Text] [Related]  

  • 13. [The complement system].
    Peltier A
    Pathol Biol (Paris); 1972 Dec; 20(23):1013-39. PubMed ID: 4119473
    [No Abstract]   [Full Text] [Related]  

  • 14. Disorders of the complement and properdin systems.
    Alper CA; Rosen FS
    Ciba Found Symp; 1972; 9():283-96. PubMed ID: 4121647
    [No Abstract]   [Full Text] [Related]  

  • 15. The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the 'reactive lysis' procedure.
    Lachmann PJ; Kay AB; Thompson RA
    Immunology; 1970 Dec; 19(6):895-9. PubMed ID: 5487541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular approach to the complement system.
    Fothergill JE; Anderson WH
    Curr Top Cell Regul; 1978; 13():259-311. PubMed ID: 352622
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement in clinical medicine.
    Frank MM; Atkinson JP
    Dis Mon; 1975 Jan; ():1-54. PubMed ID: 46195
    [No Abstract]   [Full Text] [Related]  

  • 18. The inactivation of complement and its components by plasmin.
    PILLEMER L; RATNOFF OD; BLUM L; LEPOW IH
    J Exp Med; 1953 Apr; 97(4):573-89. PubMed ID: 13052820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathways of complement activation.
    Lancet; 1973 Mar; 1(7801):473. PubMed ID: 4120378
    [No Abstract]   [Full Text] [Related]  

  • 20. Effector activating determinants on IgG. II. Differentiation of the combining sites for C1q from those for cytotoxic K cells and neutrophils by plasmin digestion of rabbits IgG.
    MacLennan IC; Connell GE; Gotch FM
    Immunology; 1974 Feb; 26(2):303-10. PubMed ID: 4277464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.